Answer
Patients taking mycophenolate mofetil are at increased risk of opportunistic bacterial, fungal, viral and protozoal infections, fatal infections and sepsis, including latent viral reactivation such as hepatitis B or C and polyomavirus infections.
Sources for this answer
- Cellcept 250mg CapsulesRoche Products Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 41Document updated
Sources checked